See other companies on Welcome to the Jungle
Our Future Health
Health research programme
- 201-500 employees
- Healthcare
- B2C
- B2B
- Charity
- Social Impact
- MedTech
- Holborn, London, UK
Jump to section
Company mission
To create an incredibly detailed picture of the UK population’s health, by recruiting up to five million adult volunteers from across the UK.
Our take
Millions of people spend too much of their life with poor health, with medical professionals only able to treat diseases when symptoms start to present. But what if later-life diseases could be prevented earlier through a better understanding of public health? Our Future Health is a ground-breaking new study, aiming to collect a blood sample and a short questionnaire from 5 million members of the British public.
One of the two major strands of genomic study in the UK (the other is the Newborn Genomes Program which will be running in parallel), Our Future Health is set to become the largest health research program in the world. With funding from government and the private sector (with particular interest from pharmaceutical investors) it will cement Britain's reputation as a world leader in genomics, and is expected to lead to major advances in the fight against obesity, diabetes, heart disease and other causes of poor health.
Aside from looking for volunteers for the study, Our Future Health is also seeking engineering talent to help build the infrastructure that will gather, analyse and protect the research data. It will be exciting to see how this charity develops and what discoveries emerge from its data in the future.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Training support to help you achieve your potential.
- We offer all employees a life assurance policy.
- Generous company pension package with employer contributions of up to 12%
- 30 days annual leave plus bank holidays.
- We have a lovely new office in Holborn, Central London and we offer flexible and remote working arrangements.
- All employees are covered by a group income protection scheme to support them in the event of long term sickness.
Company values
- We must always be honest and transparent in our intentions and with the people and partners who contribute to this programme.
- We can only achieve our goal by creating new partnerships and ways of working, bringing together people and organisations that can contribute and empowering, encouraging and supporting them to do so.
- We are ambitious and committed to reducing the impact of diseases for everyone.
- For everyone to be able to benefit from this research programme, it is critical that it represents all kinds of people.
Leadership
Andrew Roddam
(CEO, not founder)Was VP Data Strategy and Global Head of Epidemiology for GSK. Before that was the International Head for Amgen's Centre for Observational Research.
Articles
Jobs (4)
Software Engineering